Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine.
Ann Hematol
; 101(3): 717-719, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-34309715
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Purpura, Thrombotic Thrombocytopenic
/
SARS-CoV-2
/
COVID-19
/
BNT162 Vaccine
Limits:
Aged80
/
Female
/
Humans
Language:
En
Journal:
Ann Hematol
Journal subject:
HEMATOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Alemania
Country of publication:
Alemania